A Study To Assess Distribution Of RO7248824 In The Central Nervous System Following Single Intrathecal Doses Of [89zr] Labeled RO7248824 In Healthy Male Participants

Clinical trial NCT04863794 · COMPLETED

Trial details

NCT number: NCT04863794
Sponsor: Hoffmann-La Roche
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Angelman Syndrome

Start date: 2021-04-29
Primary completion: 2022-08-01
Enrollment: 21

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.